Michael Bonares

Michael Bonares

Auto-generated profile, based on publicly available information

Michael Bonares

Division of Palliative Medicine, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, Canada

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 November 2016 in IDCases
Verified
Journal Article
Open access
PDF file
MBMichael J. Bonares
Michael J. Bonares
AVAlon Vaisman
Alon Vaisman
ASAbdu Sharkawy
Abdu Sharkawy
Pseudomonas stutzeri is infrequently isolated from clinical specimens, and if isolated, more likely represents colonization or contamination rather than infection. Despite this, there are dozens of case reports which describe clinically significant P. stutzeri infections at variable sites. A 69-year-old man had a P. stutzeri infection of a prosthetic vascular graft infection, which he received in Panama City. He was successfully treated with a single antipseudomonal agent for 6 weeks and the removal of the infected vascular graft. A 70-year-old man had a P. stutzeri infection of a prosthetic joint, which was successfully treated with a single anti-pseudomonal agent for 6 weeks. There is only one other documented case of a prosthetic vascular graft infection secondary to P. stutzeri. There are 5 documented cases of P. stutzeri prosthetic joint infections. The previous cases were treated with antibiotics and variably, source control with the removal of prosthetic material. Most cases of P. stutzeri infection are due to exposure in health care settings. Immunocompromised states such as HIV or hematological and solid tumor malignancies are risk factors for P. stutzeri infection. Infections caused by P. stutzeri are far less frequent and less fatal than those caused by P. aeruginosa. The etiology of a P. stutzeri infection could be exposure to soil and water, but also contaminated material in the health care setting or an immunocompromised state. Iatrogenic infections that are secondary to health care tourism are a potential cause of fever in the returned traveler.

14 February 2023 in Journal of Pain and Symptom Management
Verified
Journal Article
Closed access
MBMichael Bonares
Michael Bonares
LLLisa W Le
Lisa W Le
Camilla ZimmermannCamilla Zimmermann
Camilla Zimmermann
KWKristen Wentlandt
Kristen Wentlandt

3 December 2021 in BMJ Supportive & Palliative Care
Verified
Journal Article
Closed access
PDF file
MBMichael Bonares
Michael Bonares
KMKenneth Mah
Kenneth Mah
DCDavid Christiansen
David Christiansen
JGJohn Granton
John Granton
AWAndrea Weiss
Andrea Weiss
KWKirsten Wentlandt
Kirsten Wentlandt
Objectives Patients with chronic respiratory disease have significant palliative care needs, but low utilisation of specialist palliative care (SPC) services. Decreased access to SPC results in unmet palliative care needs among this patient population. We sought to determine the referral practices to SPC among respirologists in Canada. Methods Respirologists across Canada were invited to participate in a survey about their referral practices to SPC. Associations between referral practices and demographic, professional and attitudinal factors were analysed using regression analyses. Results The response rate was 64.7% (438/677). Fifty-nine per cent of respondents believed that their patients have negative perceptions of palliative care and 39% were more likely to refer to SPC earlier if it was renamed supportive care. While only 2.7% never referred to SPC, referral was late in 52.6% of referring physicians. Lower frequency of referral was associated with equating palliative care to end-of-life care (p<0.001), male sex of respirologist (p=0.019), not knowing referral criteria of SPC services (p=0.015) and agreement that SPC services prioritise patients with cancer (p=0.025); higher referral frequency was associated with satisfaction with SPC services (p=0.001). Late referral was associated with equating palliative care to end-of-life care (p<0.001) and agreement that SPC services prioritise patients with cancer (p=0.013). Conclusions Possible barriers to respirologists’ timely SPC referral include misperceptions about palliative care, lack of awareness of referral criteria and the belief that SPC services prioritise patients with cancer. Future studies should confirm these barriers and evaluate the effectiveness of strategies to overcome them.

13 August 2025 in American Journal of Kidney Diseases
Verified
Journal Article
Open access
MBMichael J. Bonares
Michael J. Bonares
ABAdrianna Bruni
Adrianna Bruni
SYSamantha Yoo
Samantha Yoo
LHLyndsay Harrison
Lyndsay Harrison
WLWenshan Li
Wenshan Li
SJS. Vanita Jassal
S. Vanita Jassal
Little is known about physician-delivered palliative care and the sociodemographic and clinical factors associated with its utilization for individuals undergoing maintenance dialysis. This study described physician-delivered palliative care in the last year of life and evaluated the factors associated with utilization in this patient population. Population-level cross-sectional study. Individuals undergoing maintenance dialysis who died between April 2012 and March 2020 in Ontario, Canada. Sociodemographic factors (age, sex, immigration status, neighborhood-level income quintile, rurality, health region), comorbidities (heart failure, cirrhosis, pulmonary disease, dementia, malignancy), and kidney-specific factors (dialysis modality, access, duration; and prior kidney transplantation). Physician-delivered palliative care. Descriptive statistics characterizing physician-delivered palliative care. Logistic regression evaluating the factors associated with utilization. 18,452 decedents who underwent maintenance dialysis were included (median age=71 years; 61.1% male). 52.2% received physician-delivered palliative care in the last year of life starting a median of 23 days before death. 65% died in hospital and 12% at home. Palliative care was initiated by a family physician for 68% of those receiving physician-delivered palliative care. It was delivered in the clinic setting for 44.8%, and through a generalist-only model for 46%. The odds of receiving palliative care were higher in the setting of a malignancy, dementia, or cirrhosis; and were lower among those who were recent immigrants, lived in lower-income neighborhoods, and resided in less dense/more rural regions. The odds of dying in hospital were lower among those who received palliative care, especially if it was delivered at home. Exclusion of palliative care provided by non-physician providers; and inability to infer causal associations or to comment on the goal-concordance of end-of-life care. Over half of decedents who underwent maintenance dialysis received physician-delivered palliative care in the last year of life, albeit typically starting 3 weeks before death. This may indicate a perception that palliative care is exclusively for end-of-life care. More research is required to identify barriers to delivering equitable palliative care.

14 July 2023 in Palliative Medicine
Verified
Journal Article
Open access
MBMichael Bonares
Michael Bonares
KSKalli Stilos
Kalli Stilos
LHLise Huynh
Lise Huynh
DSDebbie Selby
Debbie Selby
Background: Patients with and without cancer are frequently hospitalized, and have specialist palliative care needs. In-hospital mortality can serve as a quality indicator of acute care. Trends in acute care outcomes have not previously been evaluated in patients with confirmed specialist palliative care needs or between diagnostic groups. Aim: To compare trends in discharge location between hospitalized patients with and without cancer who received specialist palliative care. Design: Retrospective cohort study. Association between diagnosis (cancer, non-cancer) and in-hospital mortality was assessed using multivariable logistic regression, controlling for demographic, clinical, and admission-specific information. Setting/participants: Patients who received specialist palliative care at an academic tertiary hospital in Toronto, Canada from 2013 to 2019. Results: The cohort comprised 6846 patients, 5024 with and 1822 without cancer. A higher proportion of patients without cancer had a Palliative Performance Scale score <30%, anticipated prognosis of <1 month, and were referred for end-of-life care (all p < 0.001). The adjusted odds of dying in hospital was 1.24-times higher among patients without cancer (95% CI: 1.05–1.46; p = 0.011). Though the proportion of patients without cancer who died in hospital decreased by 8.4% from 2013 to 2019, this proportion (41.2%) remained substantially higher compared to patients with cancer (14.0%) in 2019. Conclusions: Hospitalized patients without cancer were referred to specialist palliative care at a lower functional status, a poorer anticipated prognosis, and more likely for end-of-life care; and were more likely to die in hospital. Future studies are required to determine whether a proportion of hospital deaths in patients without cancer represent goal-discordant end-of-life care.

10 September 2025 in Journal of Pain and Symptom Management
Verified
Journal Article
Open access
MBMichael J. Bonares
Michael J. Bonares
JSJennifer Shapiro
Jennifer Shapiro
VVVishniha Vijayanathan
Vishniha Vijayanathan
AAAgessandro Abrahao
Agessandro Abrahao
LZLorne Zinman
Lorne Zinman
CLChristine Lau
Christine Lau
Although it is known where people with amyotrophic lateral sclerosis (ALS) are dying, less is known about whether they are dying where they want to. To determine the rate of dying in a preferred place and factors associated with doing so in people with ALS receiving clinic-based specialist palliative care. Retrospective cohort study of people with ALS receiving clinic-based specialist palliative care in Toronto, Canada between July 2022 and February 2024. Association between preferred and actual place of death was determined using a χ2 test. Factors associated with dying in a preferred place were determined using a multivariable binary logistic regression analysis. In 367 individuals, at time of consultation, median age was 67 years; 60.8% had a Palliative Performance Scale score between 50% and 60%, and 43.3% had noninvasive ventilation. Mortality rate up to February 2024 was 41.7%. About 85.4% stated a preference to die at home, 8.7% in hospital, and 5.9% in a hospice facility, whereas 54.9% died at home, 34% in hospital, and 11.1% in a hospice facility. Of those with known preferred and actual place of death, 70.1% died in a preferred place (χ2 = 36.2; P < 0.001). Dying in a preferred place was associated with increasing age (odds ratio [OR] = 1.1; 95% confidence interval [CI] = 1.0-1.1) and having noninvasive ventilation (OR = 2.5; 95% CI = 1.0-6.2). Younger age and not having noninvasive ventilation at the time of consultation may suggest a higher risk of goal-discordant end-of-life care and the need to engage in early future planning when these factors are identified.